Hainan Haiyao Co., Ltd. (SHE:000566)

China flag China · Delayed Price · Currency is CNY
4.390
-0.160 (-3.52%)
May 20, 2026, 1:35 PM CST
Market Cap5.90B -9.5%
Revenue (ttm)792.76M -5.0%
Net Income-438.08M
EPS-0.34
Shares Out1.30B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,755,500
Average Volume29,433,910
Open4.580
Previous Close4.550
Day's Range4.370 - 4.580
52-Week Range4.370 - 9.240
Beta0.49
RSI27.34
Earnings DateAug 27, 2026

About Hainan Haiyao

Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company develops intermediates, APIs, innovative chemical drugs, modern Chinese medicines, biological drugs, cellular immunity products, and high-end medical devices. It offers its products in various forms, such as pills, tablet granules, tincture fluid extracts, powders, syrups, soft capsule raw materials, powder injections, and health foods in various antibiotic series, gastrointestinal medication series, anti-tumor me... [Read more]

Sector Healthcare
Founded 1965
Employees 1,738
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000566
Full Company Profile

Financial Performance

In 2025, Hainan Haiyao's revenue was 831.18 million, a decrease of -16.10% compared to the previous year's 990.70 million. Losses were -429.99 million, -71.81% less than in 2024.

Financial Statements